Medical Device | October 21, 2021
India approves LumiraDX’s Antigen test kit
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data. The global clinical trial will evaluate vaccine candidate GBP510 against the AZ/Oxford COVID-19 vaccine
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated
